Defaults in CD200 signaling have been observed in several neuroinflammatory conditions like in multiple sclerosis (MS), Alzheimer’s disease, or in the aging brain (Hernangomez et al., 2012; Varnum et al., 2015; Xie et al., 2017). Here, CD200 is linked to myeloid sarcoma.